Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis

Simple item page
dc.contributor.authorMarcellin, Patric
dc.contributor.authorButi, Maria
dc.contributor.authorKrastev, Zahary
dc.contributor.authorDi Bisceglie, Adrian M.
dc.contributor.authorOdin, Joseph A.
dc.contributor.authorDusheiko, Geoffrey
dc.contributor.authorHeathcote, E. Jenny
dc.contributor.authorE. Jenny, Katyna
dc.contributor.authorCoombs, Derek
dc.contributor.authorMondou, Elsa
dc.contributor.authorAnderson, Jane
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.date.accessioned2022-09-15T07:21:36Z
dc.date.available2022-09-15T07:21:36Z
dc.date.issued2010-10
dc.descriptionBu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.citationMarcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.en_US
dc.identifier.endpage556Atr_TR
dc.identifier.issn0270-9139
dc.identifier.issue4, Supplementen_US
dc.identifier.startpage555Atr_TR
dc.identifier.urihttp://hdl.handle.net/11452/28736
dc.identifier.volume52tr_TR
dc.identifier.wos000288775600481tr_TR
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleContinued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysisen_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science